Georgiamune Inc.

Georgiamune Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Unique approaches to re-establishing immune balance and groundbreaking scientific discoveries have led to the development of pioneering immune therapeutics for cancer and autoimmune diseases.

Company Details

Employees
29
Address
Gaithersburg, Maryland, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Gaithersburg, Maryland
Looking for a particular Georgiamune Inc. employee's phone or email?

Georgiamune Inc. Questions

News

Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth - Yahoo Finance

Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth Yahoo Finance

Georgiamune advance second oncology drug to trials with first patient dosed - Clinical Trials Arena

Georgiamune advance second oncology drug to trials with first patient dosed Clinical Trials Arena

Today, I am proud to announce Georgiamune Inc. has reached two momentous milestones - Samir Khleif - Oncodaily

Today, I am proud to announce Georgiamune Inc. has reached two momentous milestones - Samir Khleif Oncodaily

Georgiamune Inc. Achieves US FDA Clearance for Investigational New Drug (IND) Application and Secures $75 Million in Series A Financing - PR Newswire

Georgiamune Inc. Achieves US FDA Clearance for Investigational New Drug (IND) Application and Secures $75 Million in Series A Financing PR Newswire

Healing Horizons: Georgiamune Founder Dr. Samir Khleif Aims to Unlock the Full Potential of Cancer Immunotherapy - Entrepreneur

Healing Horizons: Georgiamune Founder Dr. Samir Khleif Aims to Unlock the Full Potential of Cancer Immunotherapy Entrepreneur

WilmerHale Advises Georgiamune on $75M Series A Financing - WilmerHale

WilmerHale Advises Georgiamune on $75M Series A Financing WilmerHale

Mark Avagliano joins Georgiamune - The Pharma Letter

Mark Avagliano joins Georgiamune The Pharma Letter

Pitch Deck Georgiamune Used to Raise $75 Million From General Catalyst - businessinsider.com

Pitch Deck Georgiamune Used to Raise $75 Million From General Catalyst businessinsider.com

Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch - Yahoo Finance

Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch Yahoo Finance

Top Georgiamune Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant